SpringWorks Therapeutics ...
(SWTX)
undefined
undefined%
At close: undefined
38.30
-0.21%
After-hours Dec 13, 2024, 05:19 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 5.45M | 6.15M | - | 35.00M | - | - | - |
| Cost of Revenue | 422.00K | 1.90M | 490.00K | 349.00K | 192.00K | 17.33K | 3.18K |
| Gross Profit | 5.03M | 4.25M | -490.00K | 34.65M | -192.00K | -17.33K | -3.18K |
| Operating Income | -343.01M | -280.67M | -173.47M | -46.32M | -59.24M | -18.49M | -4.66M |
| Interest Income | 22.95M | 6.15M | 698.00K | 1.33M | 3.55M | 678.00K | 63.00K |
| Pretax Income | -325.10M | -277.42M | -173.91M | -45.57M | -58.31M | -17.81M | -4.64M |
| Net Income | -325.10M | -274.16M | -173.21M | -44.24M | -54.76M | -17.81M | -4.64M |
| Selling & General & Admin | 197.55M | 134.55M | 71.79M | 29.46M | 16.69M | 8.59M | 1.86M |
| Research & Development | 150.49M | 146.12M | 101.68M | 51.86M | 42.55M | 9.90M | 2.80M |
| Other Expenses | - | -138.00K | -152.00K | 25.00K | - | - | - |
| Operating Expenses | 348.04M | 280.67M | 173.47M | 81.32M | 59.24M | 18.49M | 4.66M |
| Interest Expense | - | - | - | - | - | - | - |
| Selling & Marketing Expenses | - | - | - | - | - | - | -3.73M |
| Cost & Expenses | 348.46M | 280.67M | 173.47M | 81.32M | 59.24M | 18.49M | 4.66M |
| Income Tax | - | -3.26M | -698.00K | -1.33M | -3.55M | 678.00K | -2 |
| Shares Outstanding (Basic) | 63.12M | 53.29M | 48.50M | 43.30M | 43.01M | 22.20M | 43.23M |
| Shares Outstanding (Diluted) | 63.12M | 53.29M | 48.50M | 43.30M | 43.01M | 22.20M | 43.23M |
| EPS (Basic) | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.8 | -0.11 |
| EPS (Diluted) | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.8 | -0.11 |
| EBITDA | -341.35M | -280.67M | -172.98M | -45.98M | -59.05M | -18.47M | -4.64M |
| Depreciation & Amortization | 1.67M | 1.90M | 490.00K | 349.00K | 192.00K | 17.33K | 3.18K |